New Implications of Patients' Sex in Today's Lung Cancer Management.

epidemiology gender immunotherapy lung cancer screening sex

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
13 Jul 2022
Historique:
received: 06 05 2022
revised: 04 07 2022
accepted: 11 07 2022
entrez: 27 7 2022
pubmed: 28 7 2022
medline: 28 7 2022
Statut: epublish

Résumé

This paper describes where and how sex matters in today's management of lung cancer. We consecutively describe the differences between males and females in lung cancer demographics; sex-based differences in the immune system (including the poorer outcomes in women who are treated with immunotherapy but no chemotherapy); the presence of oncogenic drivers and the response to targeted therapies according to sex; the greater benefit women derive from lung cancer screening and why they get screened less; and finally, the barriers to smoking cessation that women experience. We conclude that sex is an important but often overlooked factor in modern-day thoracic oncology practice.

Identifiants

pubmed: 35884463
pii: cancers14143399
doi: 10.3390/cancers14143399
pmc: PMC9316757
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Bioessays. 2011 Nov;33(11):791-802
pubmed: 21953569
J Clin Oncol. 2007 Feb 10;25(5):469-71
pubmed: 17290053
Lancet Oncol. 2019 Jul;20(7):924-937
pubmed: 31122901
Ann Oncol. 2019 Dec 1;30(12):1914-1924
pubmed: 31613312
BMJ. 2017 Feb 8;356:j347
pubmed: 28179230
N Engl J Med. 2011 Aug 4;365(5):395-409
pubmed: 21714641
Semin Thorac Cardiovasc Surg. 2011 Summer;23(2):137-45
pubmed: 22041044
BMJ Evid Based Med. 2018 Feb;23(1):1-3
pubmed: 29367314
CA Cancer J Clin. 2015 Jul-Aug;65(4):255-6
pubmed: 25944110
Int J Cancer. 2006 Aug 15;119(4):741-4
pubmed: 16557573
Lancet Oncol. 2021 Feb;22(2):198-211
pubmed: 33476593
Cancer. 2013 Nov 15;119(22):3976-83
pubmed: 24037918
Front Genet. 2019 May 03;10:260
pubmed: 31130979
Cancers (Basel). 2020 Oct 16;12(10):
pubmed: 33081402
Transl Lung Cancer Res. 2021 Feb;10(2):1091-1098
pubmed: 33718047
ESMO Open. 2021 Oct;6(5):100251
pubmed: 34455288
Cancer Epidemiol Biomarkers Prev. 2015 Apr;24(4):664-70
pubmed: 25613118
J Thorac Oncol. 2009 May;4(5):608-14
pubmed: 19357536
Am J Epidemiol. 2013 Apr 1;177(7):601-12
pubmed: 23425629
Cancer Med. 2018 Apr;7(4):1479-1489
pubmed: 29542259
Am J Clin Oncol. 2016 Feb;39(1):98-106
pubmed: 26558876
Lung Cancer. 2007 Jan;55(1):15-23
pubmed: 17084482
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
J Clin Oncol. 2022 May 1;40(13):1474-1486
pubmed: 35119908
Lung Cancer. 2019 Aug;134:127-140
pubmed: 31319971
Lung Cancer. 2020 Aug;146:134-144
pubmed: 32535225
BMJ Open. 2018 Oct 3;8(10):e021611
pubmed: 30287668
J Transl Med. 2018 Apr 11;16(1):94
pubmed: 29642948
Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 1):381-90
pubmed: 10673175
N Engl J Med. 2020 Oct 1;383(14):1328-1339
pubmed: 32997907
Thorax. 2011 Apr;66(4):301-7
pubmed: 21199818
Int J Cancer. 2020 Mar 15;146(6):1503-1513
pubmed: 31162856
Am J Prev Med. 2019 Aug;57(2):250-255
pubmed: 31248742
JAMA Netw Open. 2020 Nov 2;3(11):e2025102
pubmed: 33196807
JAMA. 2021 Mar 09;325(10):962-970
pubmed: 33687470
ERJ Open Res. 2021 Dec 27;7(4):
pubmed: 34988220
Gend Med. 2010 Oct;7(5):381-401
pubmed: 21056866
PLoS One. 2022 Mar 29;17(3):e0266052
pubmed: 35349598
N Engl J Med. 2020 Feb 6;382(6):503-513
pubmed: 31995683
J Thorac Dis. 2015 Mar;7(3):462-70
pubmed: 25922726
J Consult Clin Psychol. 2001 Aug;69(4):604-13
pubmed: 11550727
J Thorac Oncol. 2019 Oct;14(10):1732-1742
pubmed: 31260833
Am J Epidemiol. 1993 Sep 1;138(5):281-93
pubmed: 8395141
Eur J Cancer. 2019 Sep;118:142-148
pubmed: 31336289
J Gen Intern Med. 2020 Oct;35(10):3015-3025
pubmed: 32583338
J Clin Oncol. 2019 Mar 1;37(7):537-546
pubmed: 30620668
Nicotine Tob Res. 2008 Jan;10(1):55-61
pubmed: 18188745
ESMO Open. 2018 Apr 13;3(3):e000344
pubmed: 29682332
Biomedicines. 2020 Jul 21;8(7):
pubmed: 32708265
Biol Sex Differ. 2020 May 4;11(1):24
pubmed: 32366281
Ann Glob Health. 2019 Jan 22;85(1):
pubmed: 30741509
Nat Rev Immunol. 2016 Oct;16(10):626-38
pubmed: 27546235
J Am Coll Radiol. 2019 Oct;16(10):1433-1439
pubmed: 31092347
J Womens Health (Larchmt). 2011 Mar;20(3):349-57
pubmed: 21375414
Lung Cancer. 2009 Apr;64(1):34-40
pubmed: 18723240
Environ Health Toxicol. 2016 Jan 20;31:e2016001
pubmed: 26791091
Eur J Cardiothorac Surg. 2002 Feb;21(2):319-25
pubmed: 11825743
Lung Cancer. 2020 Jan;139:200-206
pubmed: 31816564
Int J Cancer. 2020 May 1;146(9):2376-2382
pubmed: 31583690
Expert Rev Respir Med. 2020 Feb;14(2):125-136
pubmed: 31829747
Addiction. 2008 May;103(5):809-21
pubmed: 18412759
Am J Respir Crit Care Med. 2015 May 15;191(10):1166-75
pubmed: 25760561
J Autoimmun. 2012 May;38(2-3):J187-92
pubmed: 22178198
Radiology. 2004 May;231(2):440-5
pubmed: 15128988
Am J Respir Crit Care Med. 2020 Oct 1;202(7):e95-e112
pubmed: 33000953
Lancet Oncol. 2018 Jun;19(6):737-746
pubmed: 29778737
J Clin Oncol. 2020 May 10;38(14):1505-1517
pubmed: 32150489
JAMA. 2021 Mar 9;325(10):988-997
pubmed: 33687469
Nicotine Tob Res. 2003 Feb;5(1):111-6
pubmed: 12745512
Br J Cancer. 1991 Jun;63(6):986-92
pubmed: 1648949
J Thorac Oncol. 2020 Oct;15(10):1657-1669
pubmed: 32599071
N Engl J Med. 2019 Nov 21;381(21):2020-2031
pubmed: 31562796
J Clin Oncol. 2005 Feb 1;23(4):850-6
pubmed: 15681530
Oncotarget. 2016 Nov 29;7(48):78985-78993
pubmed: 27738317
Br J Cancer. 2017 Apr 25;116(9):1141-1147
pubmed: 28324889
Lancet. 2021 Feb 13;397(10274):592-604
pubmed: 33581821
Am J Respir Cell Mol Biol. 2009 Feb;40(2):135-46
pubmed: 18676776
Lancet. 2019 May 4;393(10183):1819-1830
pubmed: 30955977
J Thorac Oncol. 2020 Aug;15(8):1351-1360
pubmed: 32302702
Ann Oncol. 2002 Jul;13(7):1087-93
pubmed: 12176788
Int J Cancer. 2007 Feb 15;120(4):868-74
pubmed: 17131307
Transl Oncol. 2019 Jun;12(6):819-827
pubmed: 30959265
Clin Lung Cancer. 2020 Sep;21(5):e329-e336
pubmed: 32371161
FASEB J. 2016 Feb;30(2):519-24
pubmed: 26514164

Auteurs

Jo Raskin (J)

Department of Thoracic Oncology, MOCA, Antwerp University Hospital, University of Antwerp, Drie Eikenstraat 655, 2650 Edegem, Belgium.

Annemiek Snoeckx (A)

Department of Radiology, Antwerp University Hospital, University of Antwerp, Drie Eikenstraat 655, 2650 Edegem, Belgium.

Annelies Janssens (A)

Department of Thoracic Oncology, MOCA, Antwerp University Hospital, University of Antwerp, Drie Eikenstraat 655, 2650 Edegem, Belgium.
Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Universiteitsplein 1, 2610 Antwerpen, Belgium.

Charlotte De Bondt (C)

Department of Thoracic Oncology, MOCA, Antwerp University Hospital, University of Antwerp, Drie Eikenstraat 655, 2650 Edegem, Belgium.

Reinier Wener (R)

Department of Thoracic Oncology, MOCA, Antwerp University Hospital, University of Antwerp, Drie Eikenstraat 655, 2650 Edegem, Belgium.

Mick van de Wiel (M)

Department of Thoracic Oncology, MOCA, Antwerp University Hospital, University of Antwerp, Drie Eikenstraat 655, 2650 Edegem, Belgium.

Jan P van Meerbeeck (JP)

Department of Thoracic Oncology, MOCA, Antwerp University Hospital, University of Antwerp, Drie Eikenstraat 655, 2650 Edegem, Belgium.

Evelien Smits (E)

Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Universiteitsplein 1, 2610 Antwerpen, Belgium.

Classifications MeSH